People: Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

42.11USD
22 Aug 2014
Price Change (% chg)

$-0.21 (-0.50%)
Prev Close
$42.32
Open
$42.22
Day's High
$42.33
Day's Low
$42.00
Volume
890,543
Avg. Vol
1,377,829
52-wk High
$43.27
52-wk Low
$32.70

Search Stocks

Capek, John 

Brief Biography

Dr. John M. Capek, Ph.D., is Executive Vice President - Medical Devices of Abbott Laboratories since July 2007. He is responsible for Abbott's Vascular, Diabetes Care, Ophthalmology and Animal Health businesses. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Dr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company. Dr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
1,357,580 -- 2,253,860 5,341,410

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Miles White

20,865,700

Thomas Freyman

5,881,750

Hubert Allen

3,772,840

Stephen Fussell

5,750,460

Richard Ashley

3,640,640

Brian Blaser

3,579,540
As Of 30 Dec 2013
Search Stocks